[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100459047":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":31,"locations":37,"responsibleParty":53,"collaborators":56,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":69,"eligibilityCriteria":70,"healthyVolunteers":65,"sex":71,"minAge":72,"maxAge":73,"enrollmentInfo":74,"targetDuration":26,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":26,"overallStatus":40,"whyStopped":26,"lastUpdateSubmitDate":83,"lastUpdatePostDateStruct":84,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":92},{"fullName":5,"class":6},"Turku University Hospital","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"FMT enema","ACTIVE_COMPARATOR","FMT enema 3-5 days after standard antibiotic treatment",[13],"Other: FMT",{"label":15,"type":16,"description":17,"interventionNames":18},"plasebo enema","PLACEBO_COMPARATOR","placebo",[19],"Other: placebo enema",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"OTHER","FMT","Fecal microbiota transfer from a healthy and tested volunteer",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"placebo enema","colored water enema",[15],[32],{"name":33,"role":34,"phone":35,"phoneExt":26,"email":36},"Teppo U Stenholm","CONTACT","023130000","teppo.stenholm@tyks.fi",[38],{"facility":39,"status":40,"city":41,"state":26,"zip":26,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Turku University hospital","RECRUITING","Turku","Finland","FI",{"type":45,"coordinates":46},"Point",[47,48],22.26869,60.45148,{"lat":48,"lon":47},[51],{"name":52,"role":34,"phone":35,"phoneExt":26,"email":36},"Teppo Stenholm",{"type":54,"investigatorFullName":52,"investigatorTitle":55,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"PRINCIPAL_INVESTIGATOR","Specialist in gastroenterology and internal medicine",[57,59,61],{"name":58,"class":22},"Satakunta Central Hospital",{"name":60,"class":22},"Helsinki University Central Hospital",{"name":62,"class":22},"PaijatHame Central Hospital","100459047","fmt-in-initial-cdi-100459047",false,"NCT05257538","FMT in Initial CDI","Fecal Microbiota Transplantation in Initial Clostridioides Difficile Enteritis: a Randomized, Placebo-controlled Trial","FinCDI","Inclusion Criteria:\n\n* \\>18 years\n* C. difficile PCR in feces positive and clinical symptoms of enteritis.\n* Full resolution of diarrhea during antibiotic treatment for C. difficile\n* No other ongoing antibacterial treatments.\n* No ongoing probiotics.\n* Signed informed consent.\n\nExclusion Criteria:\n\n* Pregnant\n* Ongoing need for antibacterial treatment\n* Life expectancy \\\u003C 1 year\n* Prior C. difficile infection in preceding 3 months\n* Unable to provide written consent, due to dementia for example.\n* Fecal incontinence i.e. inability to retain enema.","ALL","18 Years","120 Years",{"count":75,"type":76},140,"ESTIMATED","INTERVENTIONAL",[79],"NA","The study explores fecal microbiota transfer via retention enema after the first clostridioides difficile episode.",[82],"Clostridioides Difficile Infection","2025-04-08",{"date":85,"type":86},"2025-04-11","ACTUAL",{"date":88,"type":86},"2021-08-01",{"date":90,"type":76},"2028-02-28",{"name":5,"class":6},1]